See All Slides - tctmd.com

Slides

Presentation TCT 2012

SEDUCE: A Prospective, Randomized Trial of Drug Coated Balloon vs. Everolimus-Eluting Stent in for BMS Restenosis: Optical Coherence Tomography Assessment

Presenter: Tom Adriaenssens

October 25, 2012

Presentation TCT 2012

Future DCB Technologies: Challenges and Opportunities

Presenter: Juan Granada

October 25, 2012

Presentation TCT 2012

Development of a Drug-Coated Scoring Balloon: Preliminary Results from the PATENT-C First-in-Human Study

Presenter: Gary Gershony

October 25, 2012

$Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!$

Presentation TCT 2012

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Gilles Montalescot

October 25, 2012

Presentation TCT 2012

Debate: Prasugrel or Ticagrelor Should be Used in Nearly All Cases!

Presenter: Dominick Angiolillo

October 25, 2012

Presentation TCT 2012

Case Presentation Conclusion: Procedural and Patient Outcomes(2)

Presenter: Andreas Baumbach

October 25, 2012

Presentation TCT 2012

Case 4: Thoracic Aortic Dissection During Aortic Valve Implantation

Presenter: Ajay Sinhal

October 25, 2012

Presentation TCT 2012

Global Registry Models to Stimulate International Collaboration and Innovation

Presenter: Daniel Canos

October 25, 2012

Presentation TCT 2012

Promising LAA Closure Devices and the Structural Heart Team Approach

Presenter: Carlos Pedra

October 25, 2012

Presentation TCT 2012

OCT/FFR Correlation: Do the Combined Technologies Have a Role in Assessing Lesion Severity?

Presenter: Javier Escaned

October 25, 2012

Advertisement

Slides

SEDUCE: A Prospective, Randomized Trial of Drug Coated Balloon vs. Everolimus-Eluting Stent in for BMS Restenosis: Optical Coherence Tomography Assessment

Future DCB Technologies: Challenges and Opportunities

Development of a Drug-Coated Scoring Balloon: Preliminary Results from the PATENT-C First-in-Human Study

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Debate: Prasugrel or Ticagrelor Should be Used in Nearly All Cases!

Case Presentation Conclusion: Procedural and Patient Outcomes(2)

Case 4: Thoracic Aortic Dissection During Aortic Valve Implantation

Global Registry Models to Stimulate International Collaboration and Innovation

Promising LAA Closure Devices and the Structural Heart Team Approach

OCT/FFR Correlation: Do the Combined Technologies Have a Role in Assessing Lesion Severity?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content